Table 1.
Variable | Baseline | Follow-up | P-value* |
---|---|---|---|
| |||
Total cholesterol†, mg/dl | 145 ± 31 | 144 ± 28 | 0.73 |
LDL cholesterol†, mg/dl | 76 ± 27 | 72 ± 23 | 0.082 |
Triglycerides†, mg/dl | 162 (127 – 206) | 144 (112 – 200) | 0.011 |
HDL cholesterol†, mg/dl | 35 ± 6 | 40 ± 9 | <0.001 |
ApoB‡, mg/dl | 86 ± 23 | 77 ± 19 | <0.001 |
ApoA-I‡, mg/dl | 122 ± 17 | 131 ± 20 | <0.001 |
ApoB:ApoA-I ratio‡ | 0.72 ± 0.20 | 0.60 ± 0.17 | <0.001 |
Lp(a)‡§, nmol/L | 32 (14 – 149) | 28 (10 – 109) | <0.001 |
LDL: Low-density lipoprotein, HDL; high-density lipoprotein. Values are mean ± standard deviation or median (inter-quartile range) unless otherwise specified;
Wilcoxon signed-rank test comparing baseline and follow-up measurements.
One subject missing the follow-up value was excluded;
Three subjects missing baseline or follow-up values were excluded;
Follow-up measurements were performed at 1 year.